glycolysis chapter 14. definitions, notes sequence of 10 rxns –converts glu pyruvate –some atp...
Post on 21-Dec-2015
219 views
TRANSCRIPT
Definitions, Notes
• Sequence of 10 rxns
– Converts glu pyruvate
– Some ATP
– Divided – 5 “preparatory”, 5 “payoff”
• Glycolytic intermediates
– 6C – deriv’s of glu or fru
– 3C – deriv’s of dihydroxyacetone, glyceraldehye
• All intermediates phosph’d as esters or anhydrides
– Net neg charge
– Raises free energy of reactants
– Enz active sites specific for ADP/ATP/intermediate complexes w/ Mg+2
• 5 types of rxns
– phosphoryl transfer
– phosphoryl shift
– isomerization
– dehydration
– aldol cleavage
• In cell cytosol
• Overall
– Glu + 2 NAD+ + 2 ADP + 2 Pi 2 Pyruvate + 2 NADH + 2 H+ + 2 ATP + 2 H2O
G’o entire rxn = -85 kJ/mole
• Pyruvate prod (if aerobic cond’s) TCA e- transport/ox’ve phosph’n ATP gen’d
– From glycolysis ATP yields ~2800 kJ/mole
– No O2 = anaerobic metab = diff pathway = diff energy
Glycolysis Regulation
• 3 Cell mech’s
• 1. Reg’n enz catalytic activity
– Allosteric control
•Enz’s have sev subunits
•Modulators bind @ binding site
– Often regulatory subunit
conform’l change @ regulatory subunit
conform’l change @ catalytic subunit
Stimulation or inhibition
• 1. Reg’n enz activity -- cont’d
– (Reversible) covalent mod’n
•Enz’s have other enz’s assoc’d
•Assoc’d enz’s catalyze covalent binding (or removal) of funct’l grp to reg enz
• Stimulation or inhibition
• 2. Regulation of concent of enz’s in cell
– Rates of enz synth, degrad’n impt
– When incr’d substrate (chronic),
Incr’d transcr’n genes coding
Incr’d concent enz’s impt to pathway
• 3. Regulation of flux of substrates
– Cell can allow more substrate into cell
Incr’d activity of pathway
Incr’d prod’n
– Hormones impt
Hexokinase• Phosphoryl transfer from ATP
– Type of transferase
– Hydrol ATP ADP + Pi
• Other hexose substrates
• Cofactor Mg+2
• Reversible?
• Induced fit w/ glu binding (Chpt 6)
• Isozymes in mammals
Phosphohexose Isomerase
• Aldose ketose
• Mg+2 cofactor
• Reversible
• Mechanism through enediol intermediate
Phosphofructokinase-1 (PFK-1)
• Phosphoryl transfer w/ hydrol ATP
• Mg+2 cofactor
• Reversible?
• Regulatory enz
– Commits to glycolysis
– Impt to regulation of pathway
• Sev binding sites for modulators (Chpt 15)
PFK-1 Modulators• 1. Adenine nucleotides
PFK-1 activity (inhib’n) when [ATP] or other fuels
•ATP binds allosteric site
affinity for fru-6-PO4
activity (stim’d) when [ADP]/[AMP] OR [ATP]
•ADP/AMP bind allosterically
Stm’n PFK-1
More ATP overall in cell
• 1. Adenine nucleotides -- cont’d
– Note: If [ATP] in cell, ATP feedback inhib to decr further synth
– As ATP synth, and ATP used, [ADP], [AMP]
– Signals cell to restart ATP syth, so ADP, AMP act as “feedback stimulators” to incr ATP synth again
• 1. Adenine nucleotides -- cont’d– Also impt to balancing glycolysis w/
gluconeogenesis (“making new glucose”)
•Uses sev enz’s impt in glycolysis (reversed)
•BUT other, diff enz’s allow separation of pathways, regulation of 2 (so no “futile cycles”)
– Gluconeogenesis alternative to PFK-1 cat’d by fructose-1,6-bisphosphatase (FBPase-1)
– AMP stim’s PFK-1 (when more ATP needed by cell, much glu avail), BUT inhib’s FBPase-1 (when cell needs more glu, not enough avail to make more ATP)
• 2. Citrate
– Intermed formed in Kreb’s cycle
– PFK-1 activity when [citrate]
•Citrate binds allosteric site
•Usually concurrent w/ ATP modulation
– So feedback inhib’n
• 3. Fru-2,6-Bisphosphate
– In liver
PFK-1 activity when [Fru-2,6-bisphosphate]
•Binds allosteric site
affinity of PFK-1 for fru-6-PO4
•Acts as allosteric stimulator of PFK-1
– When Fru-2,6-bis… present, glycolysis encouraged, gluconeogenesis discouraged
• 3. Fru-2,6-Bisphosphate -- cont’d
– Helps balance glu used in cell w/ glu generated (gluconeogenesis)
– Impt to maintaining [blood glu]
•Works through hormone glucagon
• If not enough blood glu
stim’n ad cyclase/cAMP/prot kinase pathway if gluconeogenesis nec because not enough nutrient glu avail to maintain sufficient [blood glu]
Aldolase
• Reverse aldol condensation– Schiff base form’n; enamine
intermediate
• Reversible?
• Proceeds readily as 2P’s immediately subsequent rxns– Have committed to pathway
– Where was commitment?
Triose Phosphate Isomerase
• Reversible?
• Enediol intermediate (sim to phosphohexose isomerase mech)– Glu 165 –COOH, His 95 –H participate
– Lys –NH3 “holds” –PO4
• kcat/KM shows kinetically perfect enzyme activity
Priming Phase Ends Here; Payoff Phase to Begin
• 6C glu 2 3C phosph’d cmpds– More red’d more ox’d
• Consumed 2 ATP from cell– Cell energy “invested”
– Will yield more energy for cell at end of pathway
• REMEMBER: for each future step, cell has 2x the mol’s as began (each 1 glu 2 glyc-3-PO4)
Glyceraldehyde-3-PO4 Dehydrogenase
• Where did you hear about dehydrogenases before?
– HINT: 1st step leading to ATP prod'n through e- transport
• Aldehyde now carboxylic acid anhydride w/ PO4
– High G of hydrolysis (-49.3 kJ/mole)
• Cys in enz active site forms thiohemiacetal w/ glyc-3-PO4 aldehyde grp
– So S cov'ly bound to E in active site
• 1 :H- reduces NAD+
– Cofactor of enz
– Now NADH
thioester @ active site
– Energy-rich intermediate
• 2nd NAD+ enters, accepts :H- from orig NAD cofactor NADH avail to transport e- to mitoch for e-
transport/ox'v phosph'n/ATP synth
– Ox'd cofactor regen'd
• Pi enters
– Thioester good target for phosphate attack
– Energy rel'd w/ attack, cleavage of thioester by phosphate
Phosphoglycerate Kinase
• Requires Mg+2
• Substrate-level phosphorylation
– In cytosol
– Ox've phosph'n in mitoch
• Coupled w/ preceding rxn to allow overall neg G
– Book notes E inc'd into ATP "from" ox'n aldehyde (step 6) carbox acid (step 7)
Phosphoglycerate Mutase
• Reversible; ex of cov'ly mod'd enz
• Enz has impt His @ active site
– Stim'd w/ phosph'n
– Must be "primed" by:
Phosphoglycerate Mutase Mechanism
• Enz first phosph’d @ his
– By assoc’d kinase
– From ATP
• Phosph’s substrate @ C2 2,3-
Bisphospho- glycerate
• 2,3-Bisphospho glycerate re-phosphorylates enz @ active site His
– From C3 PO4
Phosph'd enz + 2-Phospho- glycerate regen'd
Enolase
• Mg+2 plays a role; dehydration rxn
• Redist'n e- in molecule activates phosphate
G of removal PO4 from phosphoenol pyruvate >>> G of removal PO4 from 2-phosphoglycerate
– Remember why??
– HINT: Next rxn . . .
Pyruvate Kinase
• Stabiliz’n w/ tautomerization ability of prod
– Much energy rel'd
– Essentially irreversible in cell
• Another substrate-level phosph'n
– Energy rel'd w/ cleavage PO4 conserved in ATP
• Regulatory enzyme
– Allosteric inhib'n when ↑[ATP]
•ATP binding ↓affinity of enz for S
•So ATP = feedback inhibitor (again)
– Inhib'n when ↑[acetyl-CoA]
•Prod of further metab
•Serves as feedback inhibitor
•May be formed when fats catabolized, when glycolysis not needed
• Regulatory enzyme – cont’d
– Inhib'n when ↑[fatty acids]
•Also tells cell glycolysis not needed
– When ATP, acetyl-CoA, FA's ↓, inhib'n relieved
Overall
• Glu + 2 NAD+ + 2 ADP + 2 Pi 2 pyruvate + 2 NADH + 2 H+ + 2 ATP + 2 H2O
• Transfer e- to electron transport chain ATP
• Enzymes probably multienzyme complexes
– Channel P of rxn 1 to become S of rxn 2
Other Carbohydrates
• Not all converted to glu, then glycolysis
• Glycogen, starch– Metab'd to glu as glu-1-PO4
•This is glycoGENolysis (NOT glycolysis)
– Then converted to glu-6-PO4
•Phosphoglucomutase cat's
– Now enters glycolytic pathway
• Both covalent mod’n and allosteric reg’n of glycogen phosphorylase– Activated through protein kinase
•Covalent mod’n
•Through ad cyclase act’n/cAMP prod’n
•When glucagon avail
•Happens when [blood glucose] decr’d
– Needed to balance glycolysis and gluconeogenesis in liver and maintain [blood glucose]
• Once blood glucose back to normal
– Glu now avail to re-enter liver cells
– Glu now can bind allosteric site on stim’d phosphorylase inhib’n phosphorylase to stop further release glu from glycogen
•Allosteric regulation
Other Carbohydrates -- cont’d
• Fructose
– Phosph'd
Fru-6-PO4
– Hexokinase
Fru-1-PO4
– Fructokinase
– Then glyceraldehyde + dihydroxyacetone phosphate
– Now enters glycolytic pathway
• Other 6C sugars
– Converted to glu or fru phosphates
• Disaccharides
– Hydrolzyed (enz's @ sm. int. surface in mammals) monosacch's
•These are absorbed
– Converted as above
– Enter glycolytic pathway